Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 11, Issue 3, Pages 799-804
Publisher
Wiley
Online
2020-02-04
DOI
10.1111/1759-7714.13281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hematologic Complications of Immune Checkpoint Inhibitors
- (2019) Elizabeth J. Davis et al. ONCOLOGIST
- Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
- (2019) Paul La Rosée et al. BLOOD
- Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
- (2019) Roser Calvo Frontiers in Pharmacology
- Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
- (2019) Abdul Rafeh Naqash et al. Journal for ImmunoTherapy of Cancer
- Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab
- (2018) Imke Satzger et al. EUROPEAN JOURNAL OF CANCER
- Management of Immune-mediated Cytopenias in the Era of Cancer Immunotherapy
- (2018) Yamin Sun et al. JOURNAL OF IMMUNOTHERAPY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report
- (2018) Masood Sadaat et al. Journal for ImmunoTherapy of Cancer
- Refractory Neutropenia Secondary to Dual Immune Checkpoint Inhibitors That Required Second-Line Immunosuppression
- (2018) Nicholas Meti et al. Journal of Oncology Practice
- Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysis
- (2018) Fausto Petrelli et al. EUROPEAN JOURNAL OF CANCER
- Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
- (2018) Nicolas Delanoy et al. Lancet Haematology
- Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies
- (2017) Alice Bernard-Tessier et al. EUROPEAN JOURNAL OF CANCER
- Macrophage activation syndrome: A new complication of checkpoint inhibitors
- (2017) Nausicaa Malissen et al. EUROPEAN JOURNAL OF CANCER
- Nivolumab-induced aplastic anemia: A case report and literature review
- (2017) Rachel R Comito et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
- (2017) Eileen Shiuan et al. Journal for ImmunoTherapy of Cancer
- Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report
- (2016) Magalie P. Tardy et al. HEMATOLOGICAL ONCOLOGY
- Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumab
- (2016) Samer Tabchi et al. LUNG CANCER
- Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
- (2016) Benjamin Y. Kong et al. MELANOMA RESEARCH
- Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia
- (2016) Ranjit Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis
- (2015) Y. Wang et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hemophilia A Induced by Ipilimumab
- (2011) Julie Delyon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab-induced thrombocytopenia in a patient with metastatic melanoma
- (2011) S Ahmad et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Neutropenia in a Patient Treated With Ipilimumab (anti–CTLA-4 Antibody)
- (2009) Mojtaba Akhtari et al. JOURNAL OF IMMUNOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started